Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 36INDUSTRY 9NETWORK 4OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 15Gynecologic 4

Conditions

Endometrial Neoplasms 2Peritoneal Neoplasms 1Fallopian Tube Neoplasms 1Advanced, Persistent, or Recurrent Endometrial Cancer 1

Interventions

Cisplatin 63Paclitaxel 56Carboplatin 38Taxes 24Radiotherapy 21Gemcitabine 16Brachytherapy 15Filgrastim 14Doxorubicin 13Topotecan 12Platinum 121,2-diaminocyclohexaneplatinum II citrate 12Docetaxel 11Radiation 7Granulocyte Colony-Stimulating Factor 7Chemotherapy, Adjuvant 7pegfilgrastim 6Surgical Procedures, Operative 6Radiotherapy, Intensity-Modulated 6Polymerase Chain Reaction 6Ifosfamide 6Etoposide 6Watchful Waiting 5Radiotherapy, Conformal 5Pemetrexed 5Gene Expression Profiling 5Fluorouracil 5Celecoxib 5Amifostine 5Observation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Letrozole × Gynecologic × Clear all
NCT04393285 2026-03-09

Abemaciclib and Letrozole to Treat Endometrial Cancer

GOG Foundation

Phase 2 Active not recruiting
53 enrolled
Gynecologic

Endometrial Neoplasms

NCT04111978 2025-09-29

MATAO

Swiss GO Trial Group

Phase 3 Recruiting
540 enrolled
Gynecologic

Fallopian Tube Neoplasms, Peritoneal Neoplasms

NCT02228681 2024-09-19

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

GOG Foundation

Phase 2 Completed
74 enrolled 13 charts
Gynecologic

Advanced, Persistent, or Recurrent Endometrial Cancer

NCT00004251 2020-04-06

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

Canadian Cancer Trials Group

Phase 2 Completed
33 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡